Tue, August 3, 2010
Mon, August 2, 2010
Fri, July 30, 2010
Thu, July 29, 2010
Wed, July 28, 2010
Tue, July 27, 2010
Mon, July 26, 2010
Fri, July 23, 2010
Thu, July 22, 2010
Wed, July 21, 2010
Tue, July 20, 2010
[ Tue, Jul 20th 2010 ] - Market Wire
00 AM EDT
Mon, July 19, 2010
Sun, July 18, 2010
Sat, July 17, 2010
Fri, July 16, 2010
Thu, July 15, 2010
Wed, July 14, 2010
Tue, July 13, 2010

AGA Medical to Host Second Quarter EarningsConference Call on Tuesday, Aug. 3, 2010


//health-fitness.news-articles.net/content/2010/ .. rningsconference-call-on-tuesday-aug-3-2010.html
Published in Health and Fitness on Thursday, July 22nd 2010 at 12:30 GMT by Market Wire   Print publication without navigation


MINNEAPOLIS--([ BUSINESS WIRE ])--AGA Medical Holdings, Inc. (AGA Medical) (Nasdaq: AGAM) will hold a live webcast to discuss its second quarter operating results on Tuesday, Aug. 3, 2010 at 8 a.m. ET (7 a.m. CT), hosted by John Barr, President and Chief Executive Officer, and Brigid Makes, Chief Financial Officer. The Company will issue an earnings release at approximately 7 a.m. ET (6 a.m. CT) also on Tuesday, Aug. 3, 2010.

To access the webcast, please go to the investor relations section of the AGA Medical website ([ www.amplatzer.com ]) and click on the webcast icon under the aIR Calendara section. The webcast will be available for replay approximately one hour after the presentation is complete.

To participate in the conference call, please dial (866) 356-4123 and enter 70381813. Please dial in at least 10 minutes prior to the call. If you do not have access to the Internet and want to listen to an audio replay of the conference call, please dial (888) 286-8010 and enter access number 64783415.

About AGA Medical

AGA Medical, based in Plymouth, Minnesota, is a leading innovator and manufacturer of medical devices for the treatment of structural heart defects and vascular abnormalities. AGA Medicala™s AMPLATZER® occlusion devices offer minimally invasive, transcatheter treatments that have been clinically shown to be safe and highly effective in defect closure. AGA Medical is the only manufacturer with occlusion devices approved to close seven different structural heart defects, with leading market positions for each of its devices. More than 1,650 articles supporting the benefits of AMPLATZER products have been published in medical literature. AGA Medical markets its AMPLATZER products in 112 countries worldwide to interventional cardiologists, electrophysiologists, interventional radiologists and vascular surgeons. More information about the company and its products can be found at [ http://www.amplatzer.com ].


Publication Contributing Sources